Late Relapses in Patients With Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy

PURPOSE: In patients with diffuse large B-cell lymphoma (DLBCL), most relapses occur within the first 2 years of diagnosis. We sought to define the rate and outcome of late relapses that occurred after achieving event-free survival at 24 months (EFS24). METHODS: We prospectively followed 1,324 patie...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Wang, Yucai, Farooq, Umar, Link, Brian K., Larson, Melissa C., King, Rebecca L., Maurer, Matthew J., Allmer, Cristine, Hefazi, Mehrdad, Thompson, Carrie A., Micallef, Ivana N., Johnston, Patrick B., Habermann, Thomas M., Witzig, Thomas E., Ansell, Stephen M., Cerhan, James R., Nowakowski, Grzegorz S.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2019
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7001527/
https://ncbi.nlm.nih.gov/pubmed/31170029
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.19.00014
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados